000			01583 a2200445 4500
005			20250514063427.0
264		0	_c20030501
008			200305s 0 0 eng d
022			_a0016-5085
024	7		_a10.1053/gast.2003.50156 _2doi
040			_aNLM _beng _cNLM
100	1		_aPardi, Darrell S
245	0	0	_aUrsodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. _h[electronic resource]
260			_bGastroenterology _cApr 2003
300			_a889-93 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAminosalicylic Acids _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aCholagogues and Choleretics _xtherapeutic use
650	0	4	_aCholangitis, Sclerosing _xdrug therapy
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aColonic Neoplasms _xepidemiology
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFolic Acid _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRisk Factors
650	0	4	_aUrsodeoxycholic Acid _xtherapeutic use
700	1		_aLoftus, Edward V
700	1		_aKremers, Walter K
700	1		_aKeach, Jill
700	1		_aLindor, Keith D
773	0		_tGastroenterology _gvol. 124 _gno. 4 _gp. 889-93
856	4	0	_uhttps://doi.org/10.1053/gast.2003.50156 _zAvailable from publisher's website
999			_c12464892 _d12464892